Humans have been using mind-altering substances for at least 9,000 years, and likely much longer. The earliest chemical evidence of a fermented alcoholic beverage dates to roughly 7000 BCE in central China, where Neolithic villagers brewed a mix of rice, honey, and fruit. Opium poppies were cultivated in the Mediterranean by around 5900 BCE. But recognizing compulsive substance use as a distinct problem, something we’d call “addiction,” is a far more recent development, emerging only in the last two centuries.
Prehistoric Roots of Drug Use
The oldest direct evidence of drug-related activity comes from pottery fragments found at the Neolithic village of Jiahu in China’s Henan province. Chemical analysis of residue absorbed into those jars confirmed the production of a fermented beverage combining rice, honey, and hawthorn fruit or grape, radiocarbon-dated to approximately 7000 BCE. These drinks held social, religious, and medicinal significance in early Chinese culture.
Opium poppy cultivation followed a separate track in western Europe. Radiocarbon dating of poppy remains from eleven Neolithic sites places the earliest confirmed use at around 5600 BCE in the Mediterranean. From there, poppies spread north and west: they appeared west of the Rhine by 5300 BCE and reached the western Alps around 5000 BCE. The opium poppy may be the only crop originally domesticated in western Europe, with at least 50 Early Neolithic sites containing poppy seeds. Notably, no poppy remains have been found at older Mesolithic sites, suggesting that cultivation began with the arrival of farming communities.
What these ancient peoples experienced was drug use, not addiction in any modern sense. They had limited supply, consumed substances in ritualized contexts, and lacked the concentrated preparations that make compulsive use more likely. The gap between occasional use of a plant and the cycle of craving and escalation we associate with addiction is enormous.
Why the Human Brain Is Vulnerable
Most common drugs of abuse, including caffeine, nicotine, and opiates, are plant-produced toxins. They evolved specifically to punish animals that ate the plants, not to reward them. This creates a genuine paradox: why would humans seek out and enjoy chemicals designed to deter consumption?
The answer lies in how these toxins interact with the brain’s signaling systems. Plant alkaloids interfere with nearly every step in neural communication, from neurotransmitter release to receptor binding. Some of these disruptions happen to mimic or amplify the brain’s own reward signals, creating a false sense that something enormously beneficial has occurred. In 1954, researchers James Olds and Peter Milner discovered that rats would press a lever up to 2,000 times per hour to stimulate certain deep brain regions near the nucleus accumbens. Later work revealed that dopamine was the key chemical in these circuits. Drugs of abuse hijack this same system, generating intense “wanting” that can persist even when the actual pleasure fades.
Genetic evidence shows humans have been metabolizing plant toxins throughout evolutionary history. Enzymes in the liver, particularly a family called cytochrome P450, show signs of long-standing selection pressure from exposure to these compounds. So human bodies have always had some defense against plant neurotoxins. But concentrated, refined, or synthetic versions of these substances overwhelm those defenses.
The 19th Century Turning Point
For most of history, drug use was limited by simple logistics: substances were consumed in their natural form, supply was seasonal, and routes of administration were slow. That changed dramatically in the 1800s. Morphine was isolated from opium in the early part of the century, and the hypodermic needle arrived mid-century, allowing drugs to reach the bloodstream almost instantly. This combination created the first widely recognized addiction crisis.
The American Civil War became a brutal case study. Morphine was administered so liberally to wounded soldiers that widespread dependence followed, earning the nickname “the soldier’s disease.” By the late 1800s, morphine and opium addiction had become a visible public health problem in the United States and Europe.
In 1898, the Bayer pharmaceutical company introduced heroin as a cough and pain remedy, with some believing it would prove less addictive than morphine. Reports of heroin addiction surfaced almost immediately.
When “Addiction” Became a Medical Concept
The word “addiction” has ancient origins, but it meant something completely different for most of its life. In Roman law, “addictio” was the act of handing a debtor over to a creditor as a kind of bondage. By the first century BCE, Latin writers had begun using the term more loosely to describe someone giving themselves over to destructive desires, though always with a nod to its legal roots. Through the 17th century, “addiction” mostly carried a positive meaning: devoting oneself to a person or pursuit.
The medical concept of addiction as we understand it today began around the turn of the 19th century, when physicians Benjamin Rush and Thomas Trotter first described compulsive alcohol use as a medical condition rather than a moral failing. This was a radical reframing. In 1956, the American Medical Association designated alcoholism a “major medical problem” and urged that alcoholics be admitted to general hospitals. The AMA defined alcoholics as people whose dependence on alcohol caused noticeable disturbance to their health, relationships, or ability to function socially and economically.
How Governments Responded
Through most of the 19th and early 20th centuries, drug use in the United States was essentially a private matter. Opium, morphine, and cocaine were available in patent medicines sold over the counter. Addiction was seen as a personal or medical problem, and treatment was provided on a fee-for-service basis with minimal government involvement.
That began to shift between 1909 and 1923 as a series of federal laws progressively criminalized nonmedical drug use. The most significant was the Harrison Narcotic Act of 1914, which required anyone who sold or distributed narcotics to register with the government and pay a tax. People caught with narcotics who weren’t registered were presumed to be breaking the law unless the drugs had been prescribed by a registered physician “in good faith.” Violations carried fines and up to five years in prison.
The law left one enormous question unanswered: could a doctor prescribe narcotics to an addict indefinitely to maintain their habit? The Treasury Department officials enforcing the law assumed not, and began prosecuting doctors who prescribed this way. In 1919, the Supreme Court sided with this position, ruling that a physician could not write prescriptions simply to keep an addict “comfortable by maintaining his customary use.” This effectively cut addicts off from legal supply and pushed addiction from the medical system into the criminal justice system, a shift whose consequences persisted for decades.
How the Diagnosis Evolved
The first edition of the Diagnostic and Statistical Manual of Mental Disorders in 1952 included substance-related conditions, but the framework has been revised repeatedly since. For years, the manual drew a line between “substance abuse” (a less severe pattern) and “substance dependence” (a more severe one), with dependence diagnosed when three or more criteria were met and abuse requiring just one.
The most recent edition, published in 2013, made significant changes based on research involving over 200,000 study participants. It combined abuse and dependence into a single diagnosis called “substance use disorder,” with severity rated on a spectrum: mild (two to three criteria met), moderate (four to five), and severe (six or more). Legal problems were dropped as a diagnostic criterion, and craving was added. This shift reflected growing evidence that addiction exists on a continuum rather than falling into neat categories of “abuser” versus “dependent.”
The reclassification also aligned tobacco use disorder with other substance disorders and moved gambling into the same diagnostic chapter, acknowledging that behavioral addictions can engage the same brain circuits as chemical ones. These changes represented the field’s clearest statement yet that addiction is a single phenomenon varying in degree, not a collection of separate moral or medical failures.